Neochem Bio Solutions IPO: Full Details, Dates, Price Band, Financials, Strengths, Risks & Complete Review
Neochem Bio Solutions Ltd has launched its SME IPO, and investors are showing strong interest due to the company’s decades-long operational history, integrated manufacturing capabilities, and diversified product portfolio.
In this article, you will find a super-detailed, easy-to-understand analysis covering IPO dates, price, business model, strengths, risks, financial performance, pros & cons, and FAQs—all optimized for SEO and compliant with Google policies.
📌 Neochem Bio Solutions IPO Key Details
| Particulars | Details |
|---|---|
| IPO Type | SME IPO |
| Bidding Dates | 2 Dec 2025 – 4 Dec 2025 |
| Minimum Investment | ₹2,23,200 (for 1 lot) |
| Lot Size | 1 Lot = 1,200 Shares |
| Issue Price Band | ₹93 – ₹98 per share |
| Face Value | ₹10 |
| Tentative Allotment Date | 05 Dec 2025 |
| Tentative Listing Date | 09 Dec 2025 |
| Issue Size | ₹44.97 Cr |
| Pre-apply Window | Available 4 days before subscription |
| Eligible Investors | Only Individual Investors |
📌 About Neochem Bio Solutions Ltd
Neochem Bio Solutions Ltd is a specialty performance chemicals manufacturer, supplying more than 350 customized chemical formulations globally.
With a strong presence in the market for over four decades, the company has built expertise in:
-
Surfactants
-
Specialty polymers
-
Textile chemicals
-
Home & personal care ingredients
-
Water-treatment chemicals
-
Paper industry chemicals
-
Industrial cleaning formulations
-
Bio-based chemicals and eco-friendly alternatives
The company was founded in 1978 and operates with an integrated R&D and in-house product development facility.
Its major manufacturing plant is located in Moraiya, Ahmedabad, with a capacity of 22,200 MTPA.
Managing Director / CEO:
Mr. Swapnil Ramashahaji Makatai
📌 Strengths of Neochem Bio Solutions
1. Integrated Manufacturing Facility
The company operates an advanced manufacturing facility with in-house production of key inputs like silicates, surfactant-based formulations, dispersants, and binders—resulting in:
-
Better quality control
-
Lower dependency on external suppliers
-
Reduced production costs
2. Strong Diversified Product Portfolio
With over 350 products across industries, the business is less dependent on any single sector.
Its products serve:
-
Textiles
-
Home care
-
Personal care
-
Water treatment
-
Coatings
-
Paper
-
Polymers
-
Surfactants
-
Emulsions
-
Bio-based solvents
3. Wide Customer Base (Domestic & International)
Neochem Bio has supplied to 186–194 domestic customers annually in recent years and 10–17 international clients across:
-
Bangladesh
-
Australia
-
Egypt
-
Vietnam
-
Singapore
-
Thailand
-
Indonesia
-
Uzbekistan
-
Canada
-
Turkey
-
Ukraine
-
South Korea
This global footprint ensures business stability.
4. R&D-Driven Growth
The company operates an R&D laboratory with testing infrastructure for:
-
New formulations
-
Process optimizations
-
Bio-based alternatives
-
Phosphate-free agents
-
Specialty industrial chemicals
5. Strong Environmental & Compliance Certifications
Neochem Bio holds:
-
ISO 9001 (Quality Management)
-
ISO 14001 (Environmental Management)
-
ISO 45001 (Health & Safety)
-
ZDHC Level 3
-
GOTS 6/7 Certifications
This strengthens its credibility among global buyers.
6. Zero Liquid Discharge (ZLD) Facility
The company treats and reuses all process-related effluents—a major compliance advantage in chemical manufacturing.
📌 Risks & Weaknesses of Neochem Bio Solutions
While the company has many strengths, the IPO comes with notable risks:
1. High Customer Concentration
A significant portion of revenues comes from a few customers.
Loss of any large client can impact revenues.
2. Raw Material Price Volatility
The textile and chemical industries face fluctuations in:
-
Petrochemical prices
-
Raw material availability
-
International commodity rates
This may affect margins.
3. Working Capital Heavy Business
The company serves industries with long credit cycles, resulting in:
-
High receivables (up to 140 days)
-
Cash flow pressure
-
Increased borrowing needs
4. Limited Capacity Expansion
Manufacturing capacity utilization has stayed within limits, and further expansion may require capex and capital infusion.
5. Geographic Risk
The primary manufacturing facility is in Ahmedabad.
Any local disruption—political, environmental, or regulatory—may impact production.
6. Financial Indebtedness
As of September 2025, financial debt stands at ₹38.54 crore.
Higher debt increases interest burden and reduces profitability.
📌 Neochem Bio Financial Performance (Based on Screenshot Data)
The company shows stability in total assets and profit capability.
Total Assets (₹ in Cr)
-
2023: ₹90.03 Cr
-
2024: ₹66.85 Cr
-
2025: ₹78.18 Cr
Profit Data (Visual Insight)
The charts indicate:
-
Improvement in profitability
-
Strong asset utilization
-
Growing revenue base
However, the fluctuations in total assets suggest capital shifts for operations or debt repayment.
📌 Pros & Cons of Neochem Bio Solutions IPO
👍 Pros
-
Four decades of industry experience
-
Strong presence in specialty chemicals
-
Integrated manufacturing & in-house R&D
-
Diversified customer base in 10+ countries
-
Strong compliance and sustainability certifications
-
Zero liquid discharge (ZLD) plant
-
Growing revenue and profit trends
👎 Cons
-
High debt levels
-
Working-capital intensive model
-
Dependency on raw material prices
-
Single-location manufacturing risk
-
Competitive chemical industry
-
Asset fluctuations over years
📌 Who Should Consider This IPO?
Good for:
✔ Long-term investors seeking exposure to the specialty chemical sector
✔ Investors who prefer companies with strong manufacturing infrastructure
✔ Those comfortable with SME IPOs and moderate risk
Avoid if:
✘ You want low-risk, stable investments
✘ You prefer large-cap or mainline IPOs
✘ You are uncomfortable with SME market volatility
📌 Application Details of Neochem Bio IPO
| Category | Price Band | Apply Range | Lot Size |
|---|---|---|---|
| Individual Investor | ₹93 – ₹98 | ₹2 – ₹5 Lakh | 1,200 shares |
📌 Neochem Bio Solutions IPO – FAQs
1. What is the issue size of Neochem Bio Solutions Ltd IPO?
The total issue size is ₹44.97 crore.
2. What is pre-apply for Neochem Bio Solutions IPO?
Pre-apply allows investors to apply 4 days before the bidding period starts.
3. When will my order get placed if I pre-apply?
Your order will go live automatically once the IPO opens.
4. When will I know if my IPO application is successful?
You will receive a confirmation message after allotment is completed.
5. What are the IPO open and close dates?
-
Opens: 2 December 2025
-
Closes: 4 December 2025
6. What is the lot size and minimum investment?
-
Lot Size: 1,200 shares
-
Minimum Investment: ₹2,23,200
7. What is the allotment date?
Tentative allotment date: 05 December 2025.
8. Where will Neochem Bio be listed?
The IPO will be listed on NSE – SME.
📌 Final Verdict – Should You Invest in Neochem Bio IPO?
Neochem Bio Solutions is a fundamentally strong specialty chemicals company with:
-
Robust manufacturing
-
Global clientele
-
R&D-focused growth
-
ESG certifications
-
Expanding product portfolio
However, being an SME IPO, it carries higher volatility and risk compared to mainline IPOs.
If you have a medium-risk appetite and prefer long-term bets in the chemical sector, this IPO may be suitable for you.
Short-term listing gains are possible but not guaranteed due to market volatility.
Comments
Post a Comment